Lista de obras -

A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation

artículo científico publicado en 2015

ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model

artículo científico publicado en 2016

Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT ⬇️

artículo científico publicado el 19 de julio de 2011

Atomic description of the immune complex involved in heparin-induced thrombocytopenia

artículo científico publicado en 2015

Biocompatible coupling of therapeutic fusion proteins to human erythrocytes

artículo científico publicado en 2018

Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody

artículo científico publicado en 2002

Determinants of PF4/heparin immunogenicity

artículo científico publicado en 2007

Dynamic antibody-binding properties in the pathogenesis of HIT.

artículo científico publicado en 2012

Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia

artículo científico publicado en 2018

Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia

artículo científico publicado en 2017

Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly

artículo científico publicado en 2007

ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model

scientific article published on 08 August 2017

Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)

artículo científico publicado en 2018

Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia ⬇️

artículo científico publicado el 19 de agosto de 2010

PF4/heparin complexes are T cell-dependent antigens

artículo científico publicado en 2005

Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment

artículo científico publicado en 2016

Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells

artículo científico publicado en 2003

Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia

artículo científico publicado en 2015

Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury

artículo científico publicado en 2016

Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models.

artículo científico publicado en 2015

Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia

artículo científico publicado en 2016

Role of monocytes and endothelial cells in heparin-induced thrombocytopenia

artículo científico publicado en 2016

Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications

artículo científico publicado en 2005

T2 magnetic resonance: a diagnostic platform for studying integrated hemostasis in whole blood--proof of concept.

artículo científico publicado en 2014

Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis

artículo científico publicado en 2012

The antigenic complex in HIT binds to B-cells via complement and complement receptor 2 (CD21).

artículo científico publicado en 2016

The role of surface PF4: glycosaminoglycan complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).

artículo científico publicado en 2006

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia

artículo científico publicado en 2004

Lista de obras de

A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation

ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model

Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT ⬇️

Atomic description of the immune complex involved in heparin-induced thrombocytopenia

Biocompatible coupling of therapeutic fusion proteins to human erythrocytes

Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody

Determinants of PF4/heparin immunogenicity

Dynamic antibody-binding properties in the pathogenesis of HIT.

Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia

Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia

Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly

ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model

Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)

Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia ⬇️

PF4/heparin complexes are T cell-dependent antigens

Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment

Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells

Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia

Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury

Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models.

Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia

Role of monocytes and endothelial cells in heparin-induced thrombocytopenia

Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications

T2 magnetic resonance: a diagnostic platform for studying integrated hemostasis in whole blood--proof of concept.

Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis

The antigenic complex in HIT binds to B-cells via complement and complement receptor 2 (CD21).

The role of surface PF4: glycosaminoglycan complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia